Pharmaceutical Executive-11-29-2007
Advertisement
Advertisement
Trending on PharmExec
1
AstraZeneca Shares Drop Following Wainua’s Failed Heart Disease Trial
2
FDA Approves Subcutaneous Sarclisa Escena for Multiple Myeloma
3
Novartis to Layoff 322 NJ Employees: Report
4
FDA Pauses Release of New CRL’s Following Citizen’s Petition
5